entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
644022,RPL22P19,pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,0.657339437167368,-1.40719152947945,2.40197378198754,-0.58584799718965,0.557977666054817,0.961473650102656,NA
644022,RPL22P19,pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,0.500438721111326,0.943982097734194,2.64138302334838,0.35738175394856,0.720806034312768,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
644022,RPL22P19,pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,0.368272547196345,1.96598057723359,3.79294480791872,0.518325648485346,0.604231080659783,0.933906632050025,A549
644022,RPL22P19,pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,0.519041694216367,-0.588324298667644,2.91381081625094,-0.201908886941608,0.839987954387781,0.986418245486816,A549
644022,RPL22P19,pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,0,NA,NA,NA,NA,NA,A549
644022,RPL22P19,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.103851877711185,-0.884946625012763,4.08045587181216,-0.216874450505882,0.82830618927682,1,sigmoid colon organoid
644022,RPL22P19,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.103851877711185,-0.930486410416868,4.08045587181216,-0.228034915619277,0.819619096768612,1,sigmoid colon organoid
